H.A.C.Pharma

activeseries-c-plus
series-c-plus
Stage
1
Investors

About

H.A.C.Pharma is a French pharmaceutical company founded in 2007, specializing in the production and distribution of essential and orphan drugs. The company offers a range of therapeutic solutions in areas such as cardiology, endocrinology, nutrition, gastroenterology, and onco-hematology, developed in collaboration with healthcare professionals.

Explore H.A.C.Pharma's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.